JP2025094154A5 - - Google Patents

Download PDF

Info

Publication number
JP2025094154A5
JP2025094154A5 JP2025046658A JP2025046658A JP2025094154A5 JP 2025094154 A5 JP2025094154 A5 JP 2025094154A5 JP 2025046658 A JP2025046658 A JP 2025046658A JP 2025046658 A JP2025046658 A JP 2025046658A JP 2025094154 A5 JP2025094154 A5 JP 2025094154A5
Authority
JP
Japan
Prior art keywords
amino acid
nucleic acid
sequence
acid sequence
fusion peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025046658A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025094154A (ja
Filing date
Publication date
Priority claimed from JP2019177337A external-priority patent/JP2020015755A/ja
Application filed filed Critical
Publication of JP2025094154A publication Critical patent/JP2025094154A/ja
Publication of JP2025094154A5 publication Critical patent/JP2025094154A5/ja
Pending legal-status Critical Current

Links

JP2025046658A 2014-03-28 2025-03-21 乳がんおよび卵巣がんワクチン Pending JP2025094154A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461972176P 2014-03-28 2014-03-28
US61/972,176 2014-03-28
JP2019177337A JP2020015755A (ja) 2014-03-28 2019-09-27 乳がんおよび卵巣がんワクチン
JP2021165941A JP7301408B2 (ja) 2014-03-28 2021-10-08 乳がんおよび卵巣がんワクチン
JP2023097667A JP7659333B2 (ja) 2014-03-28 2023-06-14 乳がんおよび卵巣がんワクチン

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023097667A Division JP7659333B2 (ja) 2014-03-28 2023-06-14 乳がんおよび卵巣がんワクチン

Publications (2)

Publication Number Publication Date
JP2025094154A JP2025094154A (ja) 2025-06-24
JP2025094154A5 true JP2025094154A5 (enExample) 2025-07-11

Family

ID=54196576

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016559329A Active JP6836400B2 (ja) 2014-03-28 2015-03-27 乳がんおよび卵巣がんワクチン
JP2019177337A Withdrawn JP2020015755A (ja) 2014-03-28 2019-09-27 乳がんおよび卵巣がんワクチン
JP2021165941A Active JP7301408B2 (ja) 2014-03-28 2021-10-08 乳がんおよび卵巣がんワクチン
JP2023097667A Active JP7659333B2 (ja) 2014-03-28 2023-06-14 乳がんおよび卵巣がんワクチン
JP2025046658A Pending JP2025094154A (ja) 2014-03-28 2025-03-21 乳がんおよび卵巣がんワクチン

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2016559329A Active JP6836400B2 (ja) 2014-03-28 2015-03-27 乳がんおよび卵巣がんワクチン
JP2019177337A Withdrawn JP2020015755A (ja) 2014-03-28 2019-09-27 乳がんおよび卵巣がんワクチン
JP2021165941A Active JP7301408B2 (ja) 2014-03-28 2021-10-08 乳がんおよび卵巣がんワクチン
JP2023097667A Active JP7659333B2 (ja) 2014-03-28 2023-06-14 乳がんおよび卵巣がんワクチン

Country Status (7)

Country Link
US (4) US10293035B2 (enExample)
EP (1) EP3122375B1 (enExample)
JP (5) JP6836400B2 (enExample)
CN (3) CN113403338B (enExample)
DK (1) DK3122375T3 (enExample)
ES (1) ES2868305T3 (enExample)
WO (1) WO2015149016A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3122375B1 (en) 2014-03-28 2021-03-03 University of Washington through its Center for Commercialization Breast and ovarian cancer vaccines
RU2751253C1 (ru) * 2017-12-13 2021-07-12 Иновио Фармасьютикалз, Инк. Противораковые вакцины, нацеленные на сурвивин, и их применения
CN109298171B (zh) * 2018-11-15 2022-06-28 武汉中生毓晋生物医药有限责任公司 醛化红细胞中内毒素的去除方法与应用
CN113851187B (zh) * 2021-09-15 2025-05-06 南方科技大学 一种糖肽表位预测方法、存储介质及终端设备
JP2025520120A (ja) * 2022-05-31 2025-07-01 ザ・ユニバーシティ・オブ・シカゴ ワクチンアジュバント用のモジュレーターの化学的スクリーン

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4906474A (en) 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4789734A (en) 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
WO1988001213A1 (en) 1986-08-18 1988-02-25 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents
US5811128A (en) 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
WO1994001133A1 (en) 1992-07-08 1994-01-20 Schering Corporation Use of gm-csf as a vaccine adjuvant
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
CA2153391C (en) 1993-01-11 2000-08-15 Kenneth Rock Inducing cytotoxic t lymphocyte responses
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5882914A (en) 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US6372490B1 (en) * 1999-02-23 2002-04-16 Curagen Corporation Nucleic acid encoding the MDM interacting protein
WO2001002556A2 (de) * 1999-06-30 2001-01-11 Max-Delbrück-Centrum für Molekulare Medizin Mittel zur diagnose, prognose und therapie maligner erkrankungen
JP2003504074A (ja) 1999-07-08 2003-02-04 ストレスゲン バイオテクノロジーズ コーポレイション インビトロでのTh1様応答の誘導
WO2001008636A2 (en) * 1999-08-03 2001-02-08 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
ES2347762T3 (es) 2000-04-28 2010-11-04 Mannkind Corporation Sincronizacion de epitopos en celulas que presentan antigenos.
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20030215460A1 (en) * 2002-05-07 2003-11-20 Schall Thomas J. Methods and compositions for inducing an immune response
AU2002950188A0 (en) 2002-07-12 2002-09-12 The University Of Adelaide Altered insulin-like growth factor binding proteins
US7632920B2 (en) * 2003-04-10 2009-12-15 Schering Corporation Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
WO2005058967A2 (en) * 2003-12-16 2005-06-30 Pierre Fabre Medicament Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
ES2319286T3 (es) * 2004-10-02 2009-05-06 Immatics Biotechnologies Gmbh Epitopos inmunogenos de linfocitos t colaboradores de antigenos de tumor humanos y utilizacion de dichos epitopos en metodos inmunoterapeuticos.
US20090170767A1 (en) * 2006-05-31 2009-07-02 Beth Israel Deaconess Medical Center Soluble Endoglin Compounds for the Treatment and Prevention of Cancer
WO2008008311A1 (en) * 2006-07-10 2008-01-17 The Trustees Of The University Of Pennsylvania Methods for administering tumor vaccines
US9060961B2 (en) * 2006-11-09 2015-06-23 University Of Washington Molecules and methods for treatment and detection of cancer
WO2008066498A1 (en) * 2006-12-01 2008-06-05 Agency For Science, Technology And Research Cancer-related protein kinases
US20090162383A1 (en) 2006-12-26 2009-06-25 Padlan Eduardo A Method for designing vaccines against constantly mutating pathogens
PT2520590T (pt) 2007-04-03 2018-11-14 Amgen Res Munich Gmbh Domínio de ligação específico de espécies cruzadas
WO2009012460A1 (en) 2007-07-19 2009-01-22 Health Research, Inc. Survivin peptides as cancer vaccines
PL2562184T3 (pl) 2007-07-27 2016-03-31 Immatics Biotechnologies Gmbh Nowe immunogenne epitopy do immunoterapii
US20100310640A1 (en) 2007-11-01 2010-12-09 Knutson Keith L Hla-dr binding peptides and their uses
WO2009123188A1 (ja) 2008-03-31 2009-10-08 株式会社バイオイミュランス MHCクラスII分子に提示されるサーバイビン(Survivin)の部分ペプチドとその利用法
US20120135033A1 (en) * 2008-05-19 2012-05-31 Anu Wallecha Multiple delivery system for heterologous antigens
CA2729403A1 (en) 2008-06-30 2010-01-07 Oncotherapy Science, Inc. Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
US8666674B2 (en) 2009-07-28 2014-03-04 Promising Future, Llc Pairing processes for preparing reactive cytotoxic T cells
ES2701626T3 (es) * 2009-12-28 2019-02-25 Oncotherapy Science Inc Anticuerpos anti-CDH3 y sus usos
US9568575B2 (en) * 2010-10-22 2017-02-14 T2 Biosystems, Inc. Conduit-containing devices and methods for analyte processing and detection
EA201391183A1 (ru) 2011-02-15 2014-02-28 Иммьюн Дизайн Корп. Способы усиления иммуногенспецифических иммунных ответов при помощи векторных вакцин
GB2503148A (en) * 2011-02-24 2013-12-18 Vermillion Inc Biomarker panels diagnostic methods and test kits for ovarian cancer
AU2012245439B2 (en) * 2011-04-20 2017-04-06 Acceleron Pharma, Inc. Endoglin polypeptides and uses thereof
US20170266269A1 (en) 2014-03-28 2017-09-21 University Of Washington Through Its Center For Commercialization Methods of identifying antigens for vaccines
EP3122375B1 (en) 2014-03-28 2021-03-03 University of Washington through its Center for Commercialization Breast and ovarian cancer vaccines

Similar Documents

Publication Publication Date Title
JP2025094154A5 (enExample)
JP2002542827A5 (enExample)
RU2016109940A (ru) Вакцина против бешенства
JP2008529558A5 (enExample)
JP2013501038A5 (enExample)
JP2009544333A5 (enExample)
JP2014527404A5 (enExample)
JP2001081042A5 (enExample)
JP2019506175A5 (enExample)
JP2020078318A5 (enExample)
JP2014507146A5 (enExample)
RU2009117325A (ru) Слитый белок теломеразной обратной транскриптазы, кодирующие его нуклеотиды и их применение
JP2012515557A5 (enExample)
RU2014135053A (ru) Иммуногены для вакцинации против вич
JP2015509707A5 (enExample)
JP2015514132A5 (enExample)
JP2003510050A5 (enExample)
JP2008530975A5 (enExample)
RU2011122615A (ru) Живой аттенуированный респираторно-синцитиальный вирус
RU2005136354A (ru) Противотуберкулезная вакцина с улучшенной эффективностью
CA2385325A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
JP2020536489A5 (enExample)
WO2006037038B1 (en) Optimized vaccines to provide protection against ebola and other viruses
JP2019534884A5 (enExample)